Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study
Rubio-Salvador, A.R.; Escudero-Vilaplana, V.; Marcos Rodríguez, J.A.; Mangues-Bafalluy, I.; Bernardez, B.; García Collado, C.; Collado-Borrell, R.; Alvarado Fernández, M.D.; Chacón López-Muñiz, J.I.; Yébenes Cortés, M.; Gómez Barrera, M.; Calleja-Hernández, M.Á. Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study. Int. J. Environ. Res. Public Health 2021, 18, 394. https://doi.org/10.3390/ijerph18020394
Rubio-Salvador AR, Escudero-Vilaplana V, Marcos Rodríguez JA, Mangues-Bafalluy I, Bernardez B, García Collado C, Collado-Borrell R, Alvarado Fernández MD, Chacón López-Muñiz JI, Yébenes Cortés M, Gómez Barrera M, Calleja-Hernández MÁ. Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study. International Journal of Environmental Research and Public Health. 2021; 18(2):394. https://doi.org/10.3390/ijerph18020394
Chicago/Turabian StyleRubio-Salvador, Ana R., Vicente Escudero-Vilaplana, José A. Marcos Rodríguez, Irene Mangues-Bafalluy, Beatriz Bernardez, Carlos García Collado, Roberto Collado-Borrell, María D. Alvarado Fernández, José I. Chacón López-Muñiz, María Yébenes Cortés, Manuel Gómez Barrera, and Miguel Á. Calleja-Hernández. 2021. "Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study" International Journal of Environmental Research and Public Health 18, no. 2: 394. https://doi.org/10.3390/ijerph18020394